Sign In   Register
x
Play video and select frame to capture or upload thumbnail
  Play   Capture Upload Own Image

Xphyto Therapeutics provides update on their rapid COVID-19 screening test with 3a-Diagnostic

By XPhyto Therapeutics Corp. in News 2nd Oct, 2020 Video Duration: 00:03:05
Xphyto Therapeutics (CSE: XPHY-OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive Vancouver with news the company is releasing new details about their rapid, disposable, point-of-care lateral flow screening test to detect COVID-19.


Rogers discusses what stage that testing is at and when he expected to be completed and brought to market.

People In This Video
No users are tagged in this video


Unable to load tooltip content.

MjInvest.com